DEFINING THE HCV INFECTIOUS WINDOW PERIOD IN THE CHIMPANZEE
黑猩猩 HCV 感染窗口期的定义
基本信息
- 批准号:7562417
- 负责人:
- 金额:$ 2.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-05-01 至 2008-04-30
- 项目状态:已结题
- 来源:
- 关键词:AnimalsBiological AssayBloodComputer Retrieval of Information on Scientific Projects DatabaseDetectionEnzymesExposure toFundingGrantHepatitis C virusIndividualInfectionInstitutionLiverModelingNucleic Acid Amplification TestsPan GenusPan troglodytesPlasmaResearchResearch PersonnelResourcesRiskSourceTimeUnited States National Institutes of HealthViruspreventtransmission processviral RNAviral detection
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
The infectious window period for hepatitis C virus (HCV), the time between exposure to the virus and the first detection of viral RNA, is not well defined. By establishing the window period, the risk of transmission of HCV by blood products can be further reduced and or prevented. The objective is to define and characterize the infectious window period for HCV in the chimpanzee model. Two chimpanzees have been selected and baseline liver enzyme levels have been determined. HCV borderline positive and negative plasma panels are being put together for the proposed studies. One chimpanzee was IV infused with 50 ml of plasma from each of five individual donors from a panel negative for HCV by nucleic acid testing (NAT). The animals become infected indicating that HCV was present below the level of detection of NAT. Additional virological and immunological assays are being performed at the represent time. Virological assays indicated that the animal rapidly cleared the infection and did not seroconvert. The planned inoculation of the second animal is on hold until a final decision is made on using a different plasma panel.
这个子项目是众多研究子项目之一
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KRISHNA H MURTHY其他文献
KRISHNA H MURTHY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KRISHNA H MURTHY', 18)}}的其他基金
IMMUNOGENICITY OF HIV CANDIDATE VACCINES IN BABOONS
HIV 候选疫苗对狒狒的免疫原性
- 批准号:
7562492 - 财政年份:2007
- 资助金额:
$ 2.8万 - 项目类别:
NEOANTIGENICITY OF RIBOFLAVIN AND LIGHT TREATED RBCS IN BABOONS
狒狒核黄素和光处理红细胞的新抗原性
- 批准号:
7562491 - 财政年份:2007
- 资助金额:
$ 2.8万 - 项目类别:
DEVELOPMENT OF HEPATITIS C VIRUS-LIKE PARTICLES AS CANDIDATE HCV VACCINE
开发丙型肝炎病毒样颗粒作为候选 HCV 疫苗
- 批准号:
7562406 - 财政年份:2007
- 资助金额:
$ 2.8万 - 项目类别:
IMMUNOGENETHERAPY OF CHRONIC HCV CARRIER CHIMPANZEES
慢性 HCV 携带者黑猩猩的免疫基因治疗
- 批准号:
7562457 - 财政年份:2007
- 资助金额:
$ 2.8万 - 项目类别:
DEVELOPMENT OF HEPATITIS C VIRUS-LIKE PARTICLES AS CANDIDATE HCV VACCINE
开发丙型肝炎病毒样颗粒作为候选 HCV 疫苗
- 批准号:
7349750 - 财政年份:2006
- 资助金额:
$ 2.8万 - 项目类别:
SYNTHETIC IGE PEPTIDE VACCINE FOR IMMUNOTHERAPY OF ALLERGY
用于过敏免疫治疗的合成 IGE 肽疫苗
- 批准号:
7349812 - 财政年份:2006
- 资助金额:
$ 2.8万 - 项目类别:
DEFINING THE HCV INFECTIOUS WINDOW PERIOD IN THE CHIMPANZEE
黑猩猩 HCV 感染窗口期的定义
- 批准号:
7349765 - 财政年份:2006
- 资助金额:
$ 2.8万 - 项目类别:
相似海外基金
Establishment of a new biological assay using Hydra nematocyst deployment
利用水螅刺丝囊部署建立新的生物测定方法
- 批准号:
520728-2017 - 财政年份:2017
- 资助金额:
$ 2.8万 - 项目类别:
University Undergraduate Student Research Awards
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
10368760 - 财政年份:2017
- 资助金额:
$ 2.8万 - 项目类别:
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
10669539 - 财政年份:2017
- 资助金额:
$ 2.8万 - 项目类别:
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
9570142 - 财政年份:2017
- 资助金额:
$ 2.8万 - 项目类别:
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
9915803 - 财政年份:2017
- 资助金额:
$ 2.8万 - 项目类别:
COVID-19 Supplemental work: POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER).
COVID-19 补充工作:用于确定组织特异性吸收电离辐射剂量的护理点生物测定(生物剂量计)。
- 批准号:
10259999 - 财政年份:2017
- 资助金额:
$ 2.8万 - 项目类别:
Drug discovery based on a new biological assay system using Yeast knock-out strain collection
基于使用酵母敲除菌株收集的新生物测定系统的药物发现
- 批准号:
21580130 - 财政年份:2009
- 资助金额:
$ 2.8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Machine learning for automatic gene annotation using high-throughput biological assay data
使用高通量生物测定数据进行自动基因注释的机器学习
- 批准号:
300985-2004 - 财政年份:2005
- 资助金额:
$ 2.8万 - 项目类别:
Postdoctoral Fellowships
Machine learning for automatic gene annotation using high-throughput biological assay data
使用高通量生物测定数据进行自动基因注释的机器学习
- 批准号:
300985-2004 - 财政年份:2004
- 资助金额:
$ 2.8万 - 项目类别:
Postdoctoral Fellowships














{{item.name}}会员




